Filter posts

Biotech Investment and Deal-making are Front and Center at #BIOCEO18

The business of making life-saving treatments is fraught with setbacks, challenges and failures. Along the …

Enter to Win a Free Company Presentation at the 2018 BIO CEO and Investor Conference

The nomination period is underway for the Buzz of BIO contest at the 2018 CEO & Investor Conference! Winners …

BIO CEO & Investor Conference Succeeds in Bringing Innovators to Investors and Vice Versa

The 19th Annual BIO CEO & Investor Conference came to a close February 14, having …

Beyond the IPO: Reverse Mergers to Tap Public Market Capital

On the opening day of the 2017 BIO CEO & Investor Conference in New York …

Good Public Policy Key to Stable Biotech Investment Climate

It is an important and exciting time for the biotechnology industry. Science is galloping forward …

Fireside Chat with Dr. Kim of Inovio Pharmaceuticals: Immunotherapies and Vaccines

The first Fireside Chat at the 2017 BIO CEO & Investor Conference was with President …

Session Recap: Applying Microbiome Research to Therapeutics

The BIO CEO & Investor Conference kicked off Monday with a panel discussion exploring how …

Biopharma Takes Aim at Opioid Abuse

Next-generation painkillers in development are non-addictive One in three Americans – roughly 100 million people …

New Programming Announced for 2017 BIO CEO & Investor Conference, Feb 13-14 Waldorf Astoria, NY.

One of the largest biotech investment conferences is just around the corner. Now in its …

Announcing BUZZ of BIO Winners for the 2017 BIO CEO & Investor Conference

BIO is pleased to announce the winners of the Buzz of BIO contest for the 2017 BIO CEO & …